Presently, only subcutaneous immunotherapy is approved by the US FDA for inhalant and stinging insect allergies in the USA. Sublingual immunotherapy (SLIT) has been used with increasing frequency ...

Hopefully this will lead to FDA approval for this treatment in ... in the production of this manuscript. Most of the sublingual immunotherapy (SLIT) data up until the latter part of this decade ...

Sublingual Film through clinical development and approval by the FDA, including filing the NDA for Anaphylm with the FDA and the following launch of Anaphylm, if approved by the FDA; that the ...